← Evidence map

ArticleEndocrine2016

Erratum to: Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia.

Nicola Ferri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2016

this papercites it

Erratum to: Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome: insights on insulin resistance, inflammation, and atherogenic dyslipidemia. | OpenQuestion